(Q35881570)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

Ibrutinib resistance in chronic lymphocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

0 references

1 reference

1 reference

chronic lymphocytic leukemia

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Y. Lynn Wang

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Richard R Furman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Shuhua Cheng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Pin Lu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Menu Setty

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Alexendar R Perez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Joelle Racchumi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Guozhou Xu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Hao Wu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Jiao Ma

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Susanne M Steggerda

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Morton Coleman

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Christina Leslie

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

language of work or name

English

0 references

publication date

28 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

The New England Journal of Medicine

19 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

2352-2354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib

19 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4512173

BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4512173

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4512173

Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4512173

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4512173

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4512173

11 July 2018

Identifiers

DOI

10.1056/NEJMC1402716

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24869597%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

PubMed publication ID

24869597

1 reference